Генетичний допінг: реалії, перспективи застосування у спорті та біоетичні аспекти
Nadiia Gorchakova, Ігор Федорович Бєленічев, Valeriia HNATIUK et al. · Fìtoterapìâ · 2023
ГЕНЕТИЧНИЙ ДОПІНГ: РЕАЛІї, ПЕРСПЕКТИВИ ЗАСТОСУВАННЯ
Cited by 1 works. doi:10.32782/2522-9680-2023-1-17 Open-access PDF
Authors
- Nadiia Gorchakova
- Ігор Федорович Бєленічев
- Valeriia HNATIUK
- Сергій ОЛІЙНИК
- О. М. Кучковський
- Юліана МОШКІВСЬКА
- Едуард ДОРОШЕНКО
References
- Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis
- The promise and challenge of therapeutic genome editing
- Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications
- The role of peroxisome proliferator-activated receptors (PPAR) in immune responses
- Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development
- PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice
- Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications
- Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors
- The approved gene therapy drugs worldwide: from 1998 to 2019
- Muscle Fiber Type Transitions with Exercise Training: Shifting Perspectives